This compound is an active pharmaceutical ingredient reference standard, structurally characterized as a quinoline derivative with a dihydroxyheptenoic acid side chain and a cyclopropyl group. It is provided for analytical and quality control applications in pharmaceutical manufacturing.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1159631-31-8
(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid
active pharmaceutical ingredient reference standard
Icomucret
active pharmaceutical ingredient reference standard
Carboxy-nifedipine
active pharmaceutical ingredient reference standard
Cinacalcet Related Compound C
active pharmaceutical ingredient reference standard
(2S,3R,4S,5S,6R)-2-[(2R,3S,4R,5R)-6-[(3,5-Dimethyl-1-adamantyl)amino]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
pharmaceutical intermediate or impurity
All-trans-Retinal
Vitamin A aldehyde metabolite
Pevonedistat Hydrochloride
NAE inhibitor antineoplastic agent
Insulin-aspart
active pharmaceutical ingredient
(Z,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid
VGYFMXBACGZSIL-DBBWNDPISA-N
C1CC1C2=NC3=CC=CC=C3C(=C2/C=C\[C@H](C[C@H](CC(=O)O)O)O)C4=CC=C(C=C4)F